Role of health technology assessment in pharmaceutical market access in developed countries

Rabia Kahveci, Wija Oortwijn, Brian Godman, E. Meltem Koç, Birol Tibet

Research output: Chapter in Book/Report/Conference proceedingChapter

24 Downloads (Pure)

Abstract

Introduction and use of a health technology in a health care setting has clinical, economic, as well as organizational, social-cultural, legal and ethical impacts. Health Technology Assessment (HTA) is a multidisciplinary field that addresses these impacts, considering healthcare context as well as available alternatives. HTA mainly aims to inform policy and clinical decision making. While systematically evaluating the effects of the health technology, HTA addresses direct and intended effects as well as the indirect and unintended effects. It is a multidisciplinary field with well-developed systematic processes and methods
Original languageEnglish
Title of host publicationPharmaceutical Market Access in Developed Markets
EditorsAlbert I. Wertheimer , Guvenc Kockaya
Place of PublicationItaly
Pages225-256
Number of pages32
Publication statusPublished - 31 Mar 2018

Keywords

  • health technology
  • pharmaceutical markets
  • developing countries

Cite this

Kahveci, R., Oortwijn, W., Godman, B., Meltem Koç, E., & Tibet, B. (2018). Role of health technology assessment in pharmaceutical market access in developed countries. In A. I. Wertheimer , & G. Kockaya (Eds.), Pharmaceutical Market Access in Developed Markets (pp. 225-256).